Hi, we've made some changes

Alizyme(AZM)

Sector:

Pharmaceuticals & Biotechnology

Index:

FTSE Small Cap

Market Cap

£39.80m

Change Today

Price Down-0.50p

Share Price

18.00p

Alizyme Overview

Alizyme is in the pharmaceuticals & biotechnology sector and is currently trading at 18.00p per share. In the last year Alizyme's share price has ranged from 17.25p to 98.50p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Income & Efficiency

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -257784.6% -653.9%
ROCE -6463.0%  

Valuation

Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 3061.4 37.0
Pr/Book 79.9  

Growth

Latest F'cast
Revenue -98.9% 8164.1%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Alizyme Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-03 a1.24 a(10.82) (7.70)p n/a n/a n/a n/a 0.0%
31-Dec-04 1.65 (5.27) (3.20)p n/a n/a n/a n/a 0.0%
31-Dec-05 an/a a(17.60) (10.10)p n/a n/a n/a n/a 0.0%
31-Dec-06 1.13 (18.97) (9.90)p n/a n/a n/a n/a 0.0%
31-Dec-07 0.01 (32.70) (15.60)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Alizyme Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-08 1.07 (7.02) (2.88)p n/a n/a n/a n/a 0.0%
31-Dec-09 1.80 (1.63) (0.43)p n/a n/a n/a n/a 0.0%

Covering analysts: Edison Investment Research, Investec Securities, Merrill Lynch

Alizyme Company Announcements

Annual Information Update 01-Jul-2008 11:09 RNS
ALIZYME LICENSES COLAL-PRED? 27-Jun-2008 07:00 RNS
Result of AGM 24-Jun-2008 11:48 RNS

Alizyme ShareCast News

TechMARK movers: Alizyme jumps on licence deal 27-Jun-2008 ShareCast
Alizyme's Colal-Pred deal worth up to €42.75m 27-Jun-2008 ShareCast
Wednesday tips round-up: M&S, JJB, Imperial Toba... 21-May-2008 ShareCast

Alizyme Top Newspaper Links

Cake maker causes a stir 25-Feb-2007 Scotland on Sunday
Hope for fat profits from weight drug that aims ... 13-Dec-2005 Telegraph
Cambridge biotech Alizyme raises £33m for drugs ... 22-Apr-2005 The Independent

Latest Alizyme Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Alizyme Market Data

Currency UK Pounds
Share Price 18.00p Price Down
Change Today -0.50p
52 Week High 98.50p
52 Week Low 17.25p
Volume 242,660
Shares Issued 221.10m
Market Cap £39.80m
Beta 0.65
RiskGrade 365

Alizyme Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
63.58% below the market average63.58% below the market average63.58% below the market average63.58% below the market average63.58% below the market average
87.95% below the sector average87.95% below the sector average87.95% below the sector average87.95% below the sector average87.95% below the sector average
Price Trend
93.89% below the market average93.89% below the market average93.89% below the market average93.89% below the market average93.89% below the market average
82.42% below the sector average82.42% below the sector average82.42% below the sector average82.42% below the sector average82.42% below the sector average
Income Not Available
Growth
31.42% below the market average31.42% below the market average31.42% below the market average31.42% below the market average31.42% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alizyme Dividends

No dividends found

Trades for 04-Jul-2008

Time Volume / Share Price
16:35 2,071 @ 18.00p
16:06 25,000 @ 17.50p
16:06 25,000 @ 17.75p
15:31 1,644 @ 17.75p
14:51 4,500 @ 17.96p

Alizyme Key Personnel

CEO Tim P McCarthy
Chair Brian Richards
Finance Director David Campbell

Digital Look have been voted
"Best Research and Information Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).